- M.Sc., Biology, University of Akron, 2004
- B.Sc., Zoology, University of Rhode Island, 1999
- Society of Environmental Toxicology and Chemistry (SETAC)
Mr. Picard has approximately 17 years of combined experience at a global contract research organization (CRO) and as a consultant. He has broad experience in ecotoxicology and, while at the CRO, served as study director on numerous aquatic and terrestrial studies with a primary focus on sediment, pollinator, and non-target terrestrial plant testing. Mr. Picard's current responsibilities include evaluating ecotoxicology data, drafting waivers and bridging arguments, conducting data gap analyses as well as reduced risk assessments. Additional responsibilities include conducting exposure modelling and risk assessment in accordance with EPA guidance. Mr. Picard is also proficient in strategically designing, placing and monitoring studies that will withstand regulatory scrutiny and facilitate registration.
Mr. Picard held leadership roles in his tenure at the global CRO including that of the technical leader for the terrestrial ecotoxicology group. He is knowledgeable with regulatory guidelines (e.g. USEPA, OECD, PMRA and JMAFF) as well as all associated Good Laboratory Practice Standards. He has directed and managed studies in support of product registrations for the pesticide (conventional and biopesticides), pharmaceutical, and industrial chemical sectors.
Mr. Picard has worked with multiple task forces and working groups that include members of industry (e.g., registrants), regulatory authorities, and the academic communities. These groups were instrumental in streamlining and validating testing guidelines such as those for chronic sediment testing in the US. He has also been heavily involved in improving various honeybee laboratory testing methods including revising the methods to assess the effects of biopesticides. Mr. Picard is an active member of the Society of Environmental Toxicology and Chemistry and participates in several interest groups (Plant, Sediment and Pharmaceutical Interest Groups) within the organization.